L3VLUP
ProSign in

OFIX in the 13F filings

Orthofix Med Inc · CUSIP 68752M108

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q1 2026Q4 2025Q3 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Quarter end
30 Jun 2023
the date the book describes
Filed
15 Aug 2023
latest of these filings; the earliest 9 Aug 2023
Managers listing it
2
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q1 2023 and Q2 2023; 1 listed it in both
Shares listed
698,288
combined, among listed positions
Reported value
$13m
combined, at the quarter end

Managers listing OFIX in Q2 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

2 of 2 holders

ActionFiling
ExodusPoint Capital Management LP447,668$8.1m0.07%Addedn.a.11 Aug 2023 (the filing on sec.gov)
First Eagle Investment Management LLC250,620$4.5munder 0.1%Added+174,6559 Aug 2023 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2023 to Q2 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
2 in Q1 2024 to 1 in Q1 2026

Tracked managers listing it, at least.

024620192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
OFIX by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20184$40mn.a.n.a.
Q4 20185$42mn.a.n.a.
Q1 20194$48mn.a.n.a.
Q2 20195$49mn.a.n.a.
Q3 20195$45mn.a.n.a.
Q4 20193$18mn.a.n.a.
Q1 20203$12mn.a.n.a.
Q2 20203$19mn.a.n.a.
Q3 20202$14mn.a.n.a.
Q4 20203$29mn.a.n.a.
Q1 20213$27mn.a.n.a.
Q2 20213$15mn.a.n.a.
Q3 20213$14mn.a.n.a.
Q4 20213$9.8mn.a.n.a.
Q1 20223$12mn.a.n.a.
Q2 20223$13mn.a.n.a.
Q3 20222$14mn.a.n.a.
Q4 20223$14mn.a.n.a.
Q1 20232$1.9mn.a.n.a.
Q2 20232$13mn.a.n.a.
Q3 20232$8.6mn.a.n.a.
Q4 20232$10m12
Q1 20242$15m20
Q2 20242$17m20
Q3 20242$3.4m01
Q4 20241$2.7m11
Q1 20251$2.6m10
Q3 20251$2.5m10
Q4 20251$2.6m1010
Q1 20261$2.3m157

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

OFIX and LLY →OFIX and JNJ →OFIX and VRTX →Choose a stock to compare with OFIX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own OFIX, latest filings →Back to the 13F Explorer →